[{"NetIncomeLoss_1_Q2_USD":14117000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":28848000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":14302000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"LiabilitiesNoncurrent_0_Q2_USD":196549000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":26653000.0,"InterestPaidNet_2_Q2_USD":13092000.0,"InventoryFinishedGoods_0_Q2_USD":2013000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0119,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-100205000.0,"Depreciation_2_Q2_USD":200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1298690.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-14354000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-7227000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":334000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":11811000.0,"AssetsCurrent_0_Q2_USD":204714000.0,"OperatingLeaseExpense_1_Q2_USD":217000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_0_Q2_USD":18569000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":23097000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":12687000.0,"SellingAndMarketingExpense_2_Q2_USD":32529000.0,"SellingAndMarketingExpense_1_Q2_USD":17022000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4884403.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4951280.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":660000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":648000.0,"InventoryValuationReserves_0_Q2_USD":135000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":892000.0,"CommonStockSharesIssued_0_Q2_shares":57000139.0,"Assets_0_Q2_USD":359695000.0,"OperatingLeaseExpense_2_Q2_USD":353000.0,"InventoryGross_0_Q2_USD":5086000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-37000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6498000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":21.32,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2368000.0,"InventoryRawMaterials_0_Q2_USD":712000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":21865000.0,"EarningsPerShareBasic_2_Q2_USD":0.38,"EarningsPerShareBasic_1_Q2_USD":0.25,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":58635195.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":58592876.0,"PrepaidExpenseCurrent_0_Q2_USD":7322000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-15000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":4000.0,"AccountsReceivableNetCurrent_0_Q2_USD":31196000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":1972000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1972000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_0_Q2_USD":18569000.0,"CommonStockValue_0_Q2_USD":1000.0,"Liabilities_0_Q2_USD":233144000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":593242000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":159686000.0,"OtherAssetsNoncurrent_0_Q2_USD":152000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":4629000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":9208000.0,"ShareBasedCompensation_2_Q2_USD":7208000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":6043000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":21503000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1128000.0,"OtherAssetsCurrent_0_Q2_USD":1559000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":660000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":175000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_0_Q2_USD":18569000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":14117000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":11177000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":21.81,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"EarningsPerShareDiluted_2_Q2_USD":0.37,"EarningsPerShareDiluted_1_Q2_USD":0.24,"RestrictedCashNoncurrent_0_Q2_USD":750000.0,"AmortizationOfFinancingCosts_2_Q2_USD":1361000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":23475000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":16089000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":7208000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3907000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":30600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":56916282.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":56940840.0,"InventoryWorkInProcess_0_Q2_USD":2361000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":875000.0,"LiabilitiesCurrent_0_Q2_USD":36595000.0,"CommonStockSharesOutstanding_0_Q2_shares":57000139.0,"AccountsPayableCurrent_0_Q2_USD":2006000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.6,"ProceedsFromStockOptionsExercised_2_Q2_USD":660000.0,"LongTermDebtNoncurrent_0_Q2_USD":195610000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":850000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":153135000.0,"GrossProfit_2_Q2_USD":110398000.0,"GrossProfit_1_Q2_USD":61134000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":100000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0066,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":124461.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":83561000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":944000.0,"NetIncomeLoss_2_Q2_USD":21503000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":160436000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":9019000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-68945000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-466692000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":12.24,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":622000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":-550000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":133495000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":73821000.0,"OperatingIncomeLoss_2_Q2_USD":37844000.0,"OperatingIncomeLoss_1_Q2_USD":23312000.0,"InventoryNet_0_Q2_USD":4951000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":34.9,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":8.22,"LiabilitiesAndStockholdersEquity_0_Q2_USD":359695000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":7058000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3807000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_0_Q2_USD":18569000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6083783.0,"AssetsNoncurrent_0_Q2_USD":154981000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":205000.0,"AccruedMarketingCostsCurrent_0_Q2_USD":1472000.0,"StockholdersEquity_0_Q2_USD":126551000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0,"OtherLiabilitiesCurrent_0_Q2_USD":1893000.0,"ProfitLoss_2_Q2_USD":21503000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":2606000.0,"OperatingExpenses_1_Q2_USD":37822000.0,"OperatingExpenses_2_Q2_USD":72554000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":9285000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":301278.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":939000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":267000.0,"Ticker":"HRMY","CIK":"1802665","name":"HARMONY BIOSCIENCES HOLDINGS, INC.","OfficialName":"Harmony Biosciences Holdings Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3078411058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210810"}]